Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase 2 3Phase NA 2Phase 4 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 92OTHER_GOV 2INDUSTRY 2FED 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 170Neoplasms 129Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 31Neoplasm Metastasis 27Skin Neoplasms 26Liver Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Interventions

Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Chronic Pain × Clear all
NCT01854229 2023-10-18

Prometra Post-Approval Study

Flowonix Medical

Phase NA Completed
400 enrolled

Cancer Pain, Back Pain, Pain, Intractable, Chronic Pain

NCT03105765 2017-04-10

Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.

Dr. Horst Schmidt Klinik GmbH

Phase NA Completed
200 enrolled

Neuralgia, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡